ADVERTISEMENT
Sears Chairman Eddie Lampert Boosts Bid to Over $5 Billion
Sears Chairman Eddie Lampert Boosts Bid to Over $5 Billion
10 Jan 2019, 08:09 PM IST
(Bloomberg) -- (Updates to include further bid conditions)
(Bloomberg) -- (Updates to include further bid conditions)
- Sears Chairman Eddie Lampert submitted a revised takeover bid in excess of $5 billion for the company, a boost from the previous $4.4 billion proposal, according to a regulatory filing.
- ESL’s revised proposal maintains conditions from its previous offer, including the requirement that a $175 million secured real estate loan be funded at closing and ESL providing half of the real estate secured loan, with other lenders providing the balance
- New bid includes the assumption of additional liabilities by over $600 million, which includes:
- Up to $166 million of payment obligations on goods which Sears ordered and has not yet taken delivery and title prior to closing
- Up to $139 million of 503(b)(9) administrative priority claims
- Up to $43 million of additional severance costs to be incurred by the Debtors
- Estimated up to $180 million of cure costs related to contracts to be assumed by ESL’s Transform Holdco
- Up to $135 million of property taxes which ESL’s Transform Holdco will acquire
- Revised bid also includes acquisition of additional assets that were previously proposed to be left with Sears’ estate
- Cyrus Capital Partners commits to a new asset-based credit facility related to the rollover commitment, a new secured real estate loan, and certain reporting persons have committed to providing equity
- Revised bid will terminate 5pm ET on Jan. 13
To contact the reporters on this story: Yueqi Yang in New York at yyang492@bloomberg.net;Nick Lichtenberg in New York at nlichtenberg@bloomberg.net
To contact the editor responsible for this story: Chakradhar Adusumilli at cadusumilli@bloomberg.net
©2019 Bloomberg L.P.
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT